Tunable resistive pulse sensing (TRPS, qNano Gold, IZON Ltd.) was investigated as a way to quantify submicron particles (SMPs) between 0.1 and 1 µm in options of biopharmaceuticals. To cut back pattern dilution, a spiking-in method was used so as to add the applicable quantity of electrolytes required for the measurement. For right particle quantification, an electrolyte focus of at the very least 50 mM sodium chloride was wanted. Intra- and inter-nanopore variability had been beneath 5% for measurement and beneath 10% for focus measurements when analyzing polystyrene normal beads.
Submicron particle counts in a stir pressured IgG1 monoclonal antibody formulation resulted in a non-symmetrical, nearly bell-shaped measurement distribution with a most at 250 nm when utilizing a NP300 nanopore (IZON Ltd.). It was proven that particle counts are closely underestimated beneath 250 nm, and due to this fact it’s endorsed to quantify particle counts by TRPS in samples with heterogeneous particle measurement distributions (e.g., biopharmaceuticals) solely ranging from the most of the histogram in the direction of the higher restrict of detection.
Extremely drug-resistant (XDR) Acinetobacter baumannii is a infamous and ceaselessly encountered pathogen demanding novel therapeutic interventions. An preliminary monoclonal antibody (MAb), C8, raised in opposition to A. baumannii capsule proved a extremely efficient remedy in opposition to a minority of medical isolates. To overcome this limitation, we broadened protection by creating a second antibody for use in a mix routine.
Retrospective immunohistochemical investigation on dolphin morbillivirus an infection by evaluating the efficiency of heterologous monoclonal and polyclonal antibodies – Short communication
Dolphin morbillivirus (DMV) is a pathogen of nice concern in free-ranging cetaceans. Confirmation and staging of morbillivirus infections depend on histology and immunohistochemistry (IHC), following molecular detection. As at the current time no particular antibodies (Abs) in opposition to DMV can be found, two heterologous Abs have been used worldwide for the examinations of morbillivirus infections of cetaceans. One is a monoclonal Ab (MoAb) ready in opposition to the N protein of canine distemper virus (CDV), whereas the different is a polyclonal Ab raised in rabbits in opposition to rinderpest virus (RPV).
Both Abs are recognized to point out cross-reactivity with DMV. In this examine we in contrast the labelling high quality and the neuroanatomical distribution of staining with these two Abs by means of IHC evaluation. To this finish, serial sections of the goal organs from ten free-ranging stranded cetaceans, beforehand recognized as being contaminated with DMV by PCR and/or serology, had been subjected to IHC. The mind, lungs and lymph nodes of one animal had been discovered to be constructive with each Abs. From two different animals, the mind and the spleen, respectively, examined constructive solely with the polyclonal Ab. In the constructive mind tissues, multifocal immunostaining was noticed, with comparable staining location and extent, with the two antibodies examined.
Our outcomes counsel that the polyclonal anti-RPV Ab may need a stronger binding exercise to DMV than the anti-CDV MoAb. Nevertheless, the elaboration and use of particular anti-DMV Abs is perhaps important to ensure conclusive outcomes in diagnostic and pathogenetic investigations. We report the isolation of two human IgG1k monoclonal antibodies (mAbs) directed in opposition to the SARS-CoV-2 spike protein. These mAbs had been remoted from two donors who had recovered from COVID-19 an infection throughout the first pandemic peak in the Lombardy area of Italy, the first European and initially most affected area in March 2020.
We used the technique of EBV immortalization of purified reminiscence B cells and supernatant screening with a spike S1/2 assay for mAb isolation. This technique allowed fast isolation of clones, with one donor exhibiting about 7% of clones constructive in opposition to spike protein, whereas the different donor didn’t produce constructive clones out of 91 examined. RNA was extracted from constructive clones 39-47 days post-EBV an infection, permitting VH and VL sequencing. The identical clones had been sequenced once more after an extra 100 days in tradition, exhibiting that no mutation had taken place throughout in vitro growth.
Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model
Induction of extreme inflammatory arthritis in the collagen antibody-induced arthritis (CAIA) murine mannequin causes in depth joint injury and pain-like habits compromising evaluation. While delicate fashions are much less extreme, their diminished, variable penetrance makes evaluation of remedy efficacy troublesome. This examine aimed to check macroscopic and microscopic modifications in the paws, together with central nervous system activation between a light and average CAIA mannequin. Balb/c mice (n=18) had been allotted to regulate, delicate, and average CAIA teams.
 Bovine Angiotensinogen ELISA Kit |
|
MBS037282-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Bovine Angiotensinogen ELISA Kit |
|
MBS037282-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Bovine Angiotensinogen ELISA Kit |
|
MBS037282-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Bovine Angiotensinogen ELISA Kit |
|
MBS037282-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Bovine Angiotensinogen ELISA Kit |
|
MBS2881823-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4630 |
Bovine Angiotensinogen ELISA Kit |
|
MBS2881823-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 440 |
Bovine Angiotensinogen ELISA Kit |
|
MBS2881823-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2480 |
Bovine Angiotensinogen ELISA Kit |
|
MBS2881823-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 580 |
Bovine Angiotensinogen ELISA Kit |
|
MBS742311-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Bovine Angiotensinogen ELISA Kit |
|
MBS742311-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Bovine Angiotensinogen ELISA Kit |
|
MBS742311-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Bovine Angiotensinogen ELISA Kit |
|
MBS742311-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
 ELISA Kit for Bovine Angiotensinogen |
|
E0797b |
EIAab |
96T |
EUR 441.6 |
 ELISA Kit ) Bovine Angiotensinogen (AGT) ELISA Kit |
|
EIA05226Bo |
Enlibio |
each |
EUR 520 |
 ELISA Kit) Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS286843-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6840 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS286843-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 480 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS286843-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3610 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS286843-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 805 |
 ELISA Kit) Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS2608749-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3545 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS2608749-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 310 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS2608749-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1940 |
Bovine Angiotensinogen (AGT) ELISA Kit |
|
MBS2608749-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 475 |
 ELISA Kit) Bovine Angiotensinogen(AGT) ELISA Kit |
|
NSL1748Bo |
Sunlong |
96 T |
EUR 528 |
|
|
|
Description: Sandwich ELISA |
) Recombinant Angiotensinogen (AGT) |
|
MBS2010720-001mg |
MyBiosource |
0.01mg |
EUR 180 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010720-005mg |
MyBiosource |
0.05mg |
EUR 330 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010720-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010720-02mg |
MyBiosource |
0.2mg |
EUR 615 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010720-05mg |
MyBiosource |
0.5mg |
EUR 1170 |
Recombinant Angiotensinogen (AGT) |
|
MBS2009330-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant Angiotensinogen (AGT) |
|
MBS2009330-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant Angiotensinogen (AGT) |
|
MBS2009330-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant Angiotensinogen (AGT) |
|
MBS2009330-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant Angiotensinogen (AGT) |
|
MBS2009330-05mg |
MyBiosource |
0.5mg |
EUR 860 |
Recombinant Angiotensinogen (AGT) |
|
MBS2011101-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant Angiotensinogen (AGT) |
|
MBS2011101-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant Angiotensinogen (AGT) |
|
MBS2011101-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant Angiotensinogen (AGT) |
|
MBS2011101-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant Angiotensinogen (AGT) |
|
MBS2011101-05mg |
MyBiosource |
0.5mg |
EUR 860 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010533-001mg |
MyBiosource |
0.01mg |
EUR 180 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010533-005mg |
MyBiosource |
0.05mg |
EUR 330 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010533-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010533-02mg |
MyBiosource |
0.2mg |
EUR 615 |
Recombinant Angiotensinogen (AGT) |
|
MBS2010533-05mg |
MyBiosource |
0.5mg |
EUR 1170 |
Recombinant Angiotensinogen (AGT) |
|
RPA797Hu01 |
Cloud-Clone |
10ug |
EUR 194 |
Recombinant Angiotensinogen (AGT) |
|
4-RPA797Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
|
|
Description: Recombinant Human Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
|
RPA797Hu02 |
Cloud-Clone |
10ug |
EUR 194 |
Recombinant Angiotensinogen (AGT) |
|
4-RPA797Hu02 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
|
|
Description: Recombinant Human Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
|
RPA797Mu01 |
Cloud-Clone |
10ug |
EUR 140 |
Recombinant Angiotensinogen (AGT) |
|
4-RPA797Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
|
|
Description: Recombinant Mouse Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
|
RPA797Ra01 |
Cloud-Clone |
10ug |
EUR 140 |
Recombinant Angiotensinogen (AGT) |
|
4-RPA797Ra01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
|
|
Description: Recombinant Rat Angiotensinogen expressed in: E.coli |
 Recombinant Human Angiotensinogen |
|
MBS954800-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Human Angiotensinogen |
|
MBS954800-002mgMammalianCell |
MyBiosource |
0.02mg(Mammalian-Cell) |
EUR 1585 |
Recombinant Human Angiotensinogen |
|
MBS954800-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Human Angiotensinogen |
|
MBS954800-01mgBaculovirus |
MyBiosource |
0.1mg(Baculovirus) |
EUR 1900 |
Recombinant Human Angiotensinogen |
|
MBS954800-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
) Recombinant Rat Angiotensinogen (Agt) |
|
MBS950608-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Rat Angiotensinogen (Agt) |
|
MBS950608-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Rat Angiotensinogen (Agt) |
|
MBS950608-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Rat Angiotensinogen (Agt) |
|
MBS950608-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Rat Angiotensinogen (Agt) |
|
MBS950608-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
) Recombinant Horse Angiotensinogen (AGT) |
|
MBS718491-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 875 |
Recombinant Horse Angiotensinogen (AGT) |
|
MBS718491-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 490 |
Recombinant Horse Angiotensinogen (AGT) |
|
MBS718491-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 695 |
Recombinant Horse Angiotensinogen (AGT) |
|
MBS718491-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 645 |
Recombinant Horse Angiotensinogen (AGT) |
|
MBS718491-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 700 |
) Recombinant Sheep Angiotensinogen (AGT) |
|
MBS948831-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Sheep Angiotensinogen (AGT) |
|
MBS948831-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Sheep Angiotensinogen (AGT) |
|
MBS948831-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Sheep Angiotensinogen (AGT) |
|
MBS948831-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Sheep Angiotensinogen (AGT) |
|
MBS948831-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
) Recombinant Mouse Angiotensinogen (Agt) |
|
MBS949091-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Mouse Angiotensinogen (Agt) |
|
MBS949091-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Mouse Angiotensinogen (Agt) |
|
MBS949091-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Mouse Angiotensinogen (Agt) |
|
MBS949091-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Mouse Angiotensinogen (Agt) |
|
MBS949091-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
 Angiotensinogen Recombinant Rabbit mAb |
|
BS48837 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
|
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
|
BS49196 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
|
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
|
BS45966 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
|
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
|
BS47031 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
|
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
|
BS47858 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
|
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
) Recombinant Chicken Angiotensinogen (AGT) |
|
MBS964225-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 875 |
Recombinant Chicken Angiotensinogen (AGT) |
|
MBS964225-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 485 |
Recombinant Chicken Angiotensinogen (AGT) |
|
MBS964225-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 705 |
Recombinant Chicken Angiotensinogen (AGT) |
|
MBS964225-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 635 |
Recombinant Chicken Angiotensinogen (AGT) |
|
MBS964225-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 700 |
 Recombinant Human Angiotensinogen Protein |
|
MBS9141858-002mg |
MyBiosource |
0.02mg |
EUR 195 |
Recombinant Human Angiotensinogen Protein |
|
MBS9141858-005mg |
MyBiosource |
0.05mg |
EUR 280 |
Recombinant Human Angiotensinogen Protein |
|
MBS9141858-01mg |
MyBiosource |
0.1mg |
EUR 385 |
Recombinant Human Angiotensinogen Protein |
|
MBS9141858-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1555 |
, partial) Recombinant Human Angiotensinogen (AGT), partial |
|
CSB-EP001463HU1 |
Cusabio |
508 mg |
Ask for price |
Recombinant Human Angiotensinogen (AGT), partial |
|
CSB-EP001463HU1-20ug |
Cusabio |
20ug |
Ask for price |
|
|
|
Description: 44-427aa |
,partial) Recombinant Human Angiotensinogen(AGT),partial |
|
AP76501 |
SAB |
1mg |
EUR 1978 |
|
|
Recombinant Human Angiotensinogen (AGT), partial |
|
MBS7110813-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 255 |
Recombinant Human Angiotensinogen (AGT), partial |
|
MBS7110813-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 405 |
Recombinant Human Angiotensinogen (AGT), partial |
|
MBS7110813-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1425 |
Recombinant Human Angiotensinogen (AGT), partial |
|
MBS7110813-5x1mgEColi |
MyBiosource |
5x1mg(E-Coli) |
EUR 6215 |
 Recombinant Human Angiotensinogen/AGT Protein |
|
RP01021 |
Abclonal |
5 μg |
EUR 209.01 |
|
|
 Recombinant Mouse Angiotensinogen/AGT Protein |
|
RP01621 |
Abclonal |
100μg |
EUR 41.8 |
|
|
 Recombinant Human Angiotensinogen, His-tagged |
|
AGT-2182H |
Creative BioMart |
10ug |
EUR 238.4 |
|
|
|
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months. |
) Recombinant Pan troglodytes Angiotensinogen (AGT) |
|
MBS1474316-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
|
MBS1474316-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
|
MBS1474316-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
|
MBS1474316-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
|
MBS1474316-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
 (NM_000029) Human Recombinant Protein) Angiotensinogen (AGT) (NM_000029) Human Recombinant Protein |
|
E45H40174M5 |
EnoGene |
20 ug |
EUR 785.42 |
 Recombinant Human Angiotensinogen Protein, His Tag |
|
E40KMP1417 |
EnoGene |
20ug |
EUR 495 |
) Angiotensinogen Protein, Human, Recombinant (His Tag) |
|
E45H51255M2-50 |
EnoGene |
50 ug |
EUR 870.73 |
) Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
|
E45M52669M2-100 |
EnoGene |
100 ug |
EUR 1046.77 |
Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
|
MBS8122693-01mg |
MyBiosource |
0.1mg |
EUR 395 |
Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
|
MBS8122693-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1635 |
Angiotensinogen Protein, Human, Recombinant (His Tag) |
|
MBS8120618-005mg |
MyBiosource |
0.05mg |
EUR 340 |
Angiotensinogen Protein, Human, Recombinant (His Tag) |
|
MBS8120618-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1380 |
) Recombinant Callithrix jacchus Angiotensinogen (AGT) |
|
MBS1361828-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
|
MBS1361828-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
|
MBS1361828-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
|
MBS1361828-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
|
MBS1361828-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
) Recombinant Human Angiotensinogen protein (C-6His) |
|
CD02340-10ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
10ug |
EUR 353 |
|
|
|
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus. |
Recombinant Human Angiotensinogen protein (C-6His) |
|
CD02340-50ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ug |
EUR 1035 |
|
|
|
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus. |
) Recombinant Rat Angiotensinogen/AGT protein (His tag) |
|
MBS2571490-002mg |
MyBiosource |
0.02mg |
EUR 305 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
|
MBS2571490-01mg |
MyBiosource |
0.1mg |
EUR 490 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
|
MBS2571490-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2185 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
|
PDMR100022-100ug |
Elabscience Biotech |
100ug |
EUR 499 |
|
|
|
Description: Rat |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
|
PDMR100022-20ug |
Elabscience Biotech |
20ug |
EUR 299 |
|
|
|
Description: Rat |
 Recombinant Human Angiotensinogen, His-GST-tagged |
|
AGT-2183H |
Creative BioMart |
10ug |
EUR 238.4 |
|
|
|
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months. |
) Recombinant Human Angiotensinogen/AGT Protein (His Tag) |
|
PKSH032069-10ug |
Elabscience Biotech |
10ug |
EUR 223 |
|
|
|
Description: Human |
Recombinant Human Angiotensinogen/AGT Protein (His Tag) |
|
PKSH032069-50ug |
Elabscience Biotech |
50ug |
EUR 593 |
|
|
|
Description: Human |
) Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
|
MBS1450817-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
|
MBS1450817-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
|
MBS1450817-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
|
MBS1450817-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
|
MBS1450817-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
) Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
|
AP75516 |
SAB |
1mg |
EUR 3489 |
|
|
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
|
CB56-10ug |
Novoprotein |
10ug |
EUR 242.4 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
|
CB56-1mg |
Novoprotein |
1mg |
EUR 2983.2 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
|
CB56-500ug |
Novoprotein |
500ug |
EUR 2106 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
|
CB56-50ug |
Novoprotein |
50ug |
EUR 595.2 |
|
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
) Recombinant Coturnix coturnix japonica Angiotensinogen (AGT) |
|
MBS1022338-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 875 |
Recombinant Coturnix coturnix japonica Angiotensinogen (AGT) |
|
MBS1022338-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 485 |
Recombinant Coturnix coturnix japonica Angiotensinogen (AGT) |
|
MBS1022338-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 705 |
Recombinant Coturnix coturnix japonica Angiotensinogen (AGT) |
|
MBS1022338-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 635 |
Recombinant Coturnix coturnix japonica Angiotensinogen (AGT) |
|
MBS1022338-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 700 |
 Angiotensinogen |
|
AP78663 |
SAB |
1mg |
EUR 2640 |
|
|
Angiotensinogen |
|
AP80389 |
SAB |
1mg |
EUR 2640 |
|
|
Angiotensinogen |
|
AP80434 |
SAB |
1mg |
EUR 2640 |
|
|
Angiotensinogen |
|
AP80686 |
SAB |
1mg |
EUR 2640 |
|
|
Angiotensinogen |
|
AP80847 |
SAB |
1mg |
EUR 2640 |
|
|
Angiotensinogen |
|
E8ET1612-48 |
EnoGene |
100ul |
EUR 275 |
|
Description: Available in various conjugation types. |
Angiotensinogen |
|
MBS8534155-01mL |
MyBiosource |
0.1mL |
EUR 345 |
Angiotensinogen |
|
MBS8534155-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
Angiotensinogen |
|
MBS8534155-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
Angiotensinogen |
|
MBS8534155-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
Paw irritation, bone quantity (BV), and paw quantity (PV) had been assessed. Histologically, the entrance paws had been assessed for joint irritation, cartilage injury, and pre/osteoclast-like cells and the lumbar spinal wire and the periaqueductal grey (PAG) area of the mind for glial reactivity. A average CAIA dose induced (1) considerably larger native paw irritation, inflammatory cell infiltration, and PV; (2) considerably extra osteoclast-like cells on the bone floor and inside the surrounding comfortable tissue; and (3) considerably larger glial reactivity inside the PAG in contrast with the delicate CAIA mannequin. These findings assist the use of a average CAIA mannequin (increased dose of monoclonal antibodies with low-dose lipopolysaccharide) to induce extra constant histopathological options, with out extreme joint destruction.
